These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 32660414)

  • 1. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.
    Strauss J; Kaplan GG; Beck PL; Rioux K; Panaccione R; Devinney R; Lynch T; Allen-Vercoe E
    Inflamm Bowel Dis; 2011 Sep; 17(9):1971-8. PubMed ID: 21830275
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
    Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
    Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
    Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
    Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
    Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
    World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of
    Kim YJ; Kim BK; Park SJ; Kim JH
    World J Gastroenterol; 2021 Aug; 27(29):4879-4889. PubMed ID: 34447232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fecal microbial markers in colorectal cancer detection.
    Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
    Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beware of pharyngeal Fusobacterium nucleatum in COVID-19.
    Bao L; Zhang C; Lyu J; Yan C; Cao R; Pan M; Li Y
    BMC Microbiol; 2021 Oct; 21(1):277. PubMed ID: 34635053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
    Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
    Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum: an emerging gut pathogen?
    Allen-Vercoe E; Strauss J; Chadee K
    Gut Microbes; 2011 Sep; 2(5):294-8. PubMed ID: 22067936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
    Wang N; Fang JY
    Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice.
    Torres J; Hu J; Seki A; Eisele C; Nair N; Huang R; Tarassishin L; Jharap B; Cote-Daigneault J; Mao Q; Mogno I; Britton GJ; Uzzan M; Chen CL; Kornbluth A; George J; Legnani P; Maser E; Loudon H; Stone J; Dubinsky M; Faith JJ; Clemente JC; Mehandru S; Colombel JF; Peter I
    Gut; 2020 Jan; 69(1):42-51. PubMed ID: 31036757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases.
    Manandhar I; Alimadadi A; Aryal S; Munroe PB; Joe B; Cheng X
    Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G328-G337. PubMed ID: 33439104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.